Michinori Matsumoto

16PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersHaematological tumoursEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Gastroenterology and hepatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 12, 2026
Early thyroid-stimulating hormone dynamics predict outcomes in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

|Jul 03, 2026
Surgical Outcomes and Recurrence Management in Borderline Resectable Hepatocellular Carcinoma: Implications for Multidisciplinary Strategies.

|Jun 03, 2026
Prognostic stratification of unresectable locally advanced pancreatic cancer using a combination of inflammatory and nutritional indices: a retrospective cohort study.

|Apr 20, 2026
Impact of Preoperative Factors of Dialysis Patients Who Underwent Pancreaticoduodenectomy on Postoperative Complications, 30-Day and Operative Mortality: Analysis Using the Japanese National Clinical Database.

|Feb 12, 2026
Association of Signal Heterogeneity in the Hepatobiliary Phase of Gd-EOB-DTPA-Enhanced MRI With Survival Outcomes and Tumor Microenvironment in Hepatocellular Carcinoma.

Munetoshi Akaoka, Koichiro Haruki, Jun Woo

|Jan 06, 2026
Impact of thyroid-stimulating hormone ratio change on the progression-free survival of patients receiving gemcitabine, cisplatin, and durvalumab therapy for advanced biliary tract cancer.

Michinori Matsumoto, Shinji Itoh, Masashi Tsunematsu

Pageof 3

Frequent Collaborators

9 joint publications

Koichiro Haruki

8 joint publications

Toru Ikegami

6 joint publications

Masashi Tsunematsu

6 joint publications

Kenei Furukawa